Almonertinib (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib is used for the research of the non-small cell lung cancer[1][2].
Molecular Weight:
525.64
Purity:
99.83
CAS Number:
[1899921-05-1]
Formula:
C30H35N7O2
Target:
EGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
